| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The next Gordon Research Conference on Prolactin will be held in Ventura, California, from Jan. 27Feb. 1, 2002. As has been the case for the past several years, we will also address similar issues for growth hormone. There are two highlighted presentations: The meeting begins with a debate on Sunday evening entitled, "Do prolactin and growth hormone cause cancer?" M. G. Rosenfeld will end the meeting with the Keynote Address on Thursday evening, speaking on "Genetic control of pituitary development." Morning and evening sessions during the week will cover various aspects of PRL and GH secretion, receptors, and actions, including mouse models, microarray analysis and proteomics, PRL and GH physiology, pituitary development and regulation, agonists, antagonists and assays, effects in peripheral tissues, behavior and lifestyles, and PRL and GH signaling. There will also be eight Platform Presentations by graduate students, postdoctoral fellows, or junior faculty, who will present late-breaking, up-to-the-minute results from their submitted abstracts. The remaining abstracts will be presented in two poster sessions. For more information on the full program or GRC registration, check the Web site at http://www.grc.org.
Paul Kelly, Chair, 2002 Prolactin GRC
Kelly{at}necker.fr
| ||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |